blindness from glp 1 GLP-1s and Eye Health: What You Need to Know Lawsuits claiming Ozempic, other GLP-1s

For persistent bloating

doi: 10.1016/j.molmet.2022.101533, 50

Obesity is now recognized as a chronic, relapsing disease associated with increased risk of more than 200 conditions, including [3]: Type 2 diabetes Cardiovascular disease Obstructive sleep apnea Certain cancers Increased overall mortality Beyond individual patient risk, the system-level burden is substantial

According to WTWs survey, employers that currently cover GLP-1 medications are also implementing restrictions

New patient prescriptions for GLP-1s rose 16% from September 2024 to September 2025, accounting for an additional 2.9 million scripts

ADDF catalyzes and funds drug discovery and drug development for cognitive aging and Alzheimers disease